Advanced Malignancies Recruiting Phase 1 Trials for Cabiralizumab (DB15082)

IndicationStatusPhase
DBCOND0030888 (Advanced Malignancies)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs